8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed Feb 26, 2026 · 4mo ago · Accession 0001171843-26-001119
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- 8-K
- Filing date
- Feb 26, 2026
- Report date
- Feb 26, 2026
- Document
- f8k_022626.htm
- Size
- 425 KB